Gynecomastia Treatment in Dubai: Male Breast Tissue Care by Dr. Ali Aldibbiat
20+ Years Clinical Experience | FRCP (London) | FRCP (Edinburgh) | PhD Researcher | FACE | Associate Professor | Jumeirah, Dubai
Gynecomastia is a condition many men feel embarrassed to discuss, but it is far more common than most realize. Excess breast tissue in men is not a cosmetic problem waiting for surgery. In the majority of cases it has an identifiable hormonal, medication-related, or physiological cause that can be treated without any procedure at all. Gynecomastia treatment Dubai begins with a thorough hormonal workup to find that cause. Dr. Ali Aldibbiat provides specialist gynecomastia treatment in Dubai at his Jumeirah clinic, establishing whether the breast tissue is true gynecomastia or pseudogynecomastia, identifying the underlying cause, and selecting the most appropriate management.
What Is Gynecomastia?
Gynecomastia is the benign proliferation of glandular breast tissue in men, caused by an imbalance between estrogen and androgen activity in breast tissue. It is distinct from pseudogynecomastia, which is fatty tissue deposition in the chest from obesity without true glandular proliferation. True gynecomastia involves palpable, sometimes tender, firm glandular tissue beneath the nipple-areola complex and requires hormonal assessment regardless of severity.
The breast gland in men responds to the same hormonal signals as in women. When the ratio of estrogen to androgen at the breast tissue level rises, whether from excess estrogen production, reduced androgen, or increased androgen-to-estrogen conversion, glandular tissue begins to proliferate. This hormonal imbalance can arise from many causes: puberty, obesity, liver disease, testicular tumors, medications, and hypogonadism among them.
Understanding this distinction matters in clinical practice. A man with pseudogynecomastia from obesity requires weight management, not surgical referral. A man with true gynecomastia from hyperprolactinemia requires cabergoline, not a surgeon. A man with gynecomastia from an anabolic steroid cycle requires careful hormonal recovery management. The approach to gynecomastia treatment in Dubai must be matched to the actual diagnosis.
What Causes Gynecomastia? The Hormonal and Non-Hormonal Drivers
Identifying the cause is the most important step in gynecomastia treatment Dubai. It determines whether care involves hormonal treatment, medication changes, surgical referral, or reassurance.
Puberty and Physiological Gynecomastia
Pubertal gynecomastia affects up to 65% of adolescent boys, usually appearing between ages 12 and 15. Most cases resolve within 6 to 24 months, but assessment confirms that no pathological cause is present.
Hypogonadism and Low Testosterone
Testosterone deficiency shifts breast tissue toward estrogen dominance. Causes can include pituitary disease, hyperprolactinemia, Klinefelter syndrome, orchitis, and age-related hormonal decline.
Obesity and Aromatase Excess
Adipose tissue converts testosterone to oestradiol through aromatase. Weight loss can reduce this hormonal drive, although established glandular tissue may not fully regress with weight loss alone.
Medications
Spironolactone, finasteride, anabolic steroids, testosterone therapy, some antipsychotics, antiandrogens, proton pump inhibitors, and antiretrovirals can contribute. A full medication review is essential.
Hyperprolactinemia
Elevated prolactin can suppress LH and testosterone, producing secondary hypogonadism. Treating a prolactinoma with cabergoline may restore testosterone and resolve gynecomastia without breast surgery.
Testicular Tumours and Other Causes
Testicular germ-cell tumours can raise beta-hCG and estrogen. Rapid unilateral onset requires examination and ultrasound; liver disease and hyperthyroidism can also disturb the estrogen-androgen balance.
Symptoms of Gynecomastia and the Assessment Approach
Gynecomastia may be found during a routine examination or present with noticeable swelling and tenderness. Clinical assessment distinguishes glandular tissue from chest fat and identifies features requiring further investigation.
Breast Swelling and Tenderness
Glandular tissue usually feels firm and rubbery beneath the nipple and may be tender during the early, active phase. Longstanding tissue often becomes less tender as fibrosis develops.
True Gynecomastia vs Pseudogynecomastia
True gynecomastia is a firm, nipple-centred glandular disc. Pseudogynecomastia is softer, diffuse fatty tissue. Examination usually distinguishes them, with ultrasound used when uncertainty remains.
Unilateral vs Bilateral
Bilateral cases are commonly physiological, medication-related, or systemic. Rapid unilateral enlargement, a fixed lump, nipple discharge, or skin changes requires urgent assessment to exclude male breast cancer.
Associated Symptoms to Report
Report rapid progression, testicular changes, reduced libido, fatigue, loss of body hair, headaches, visual changes, new medications, anabolic steroid use, or a family history of breast or testicular cancer.
When Should You See a Doctor for Gynecomastia?
Not every case requires urgent investigation. The following changes and associated symptoms warrant specialist gynecomastia treatment Dubai assessment without delay.
New Unilateral Changes
A firm, fixed, or rapidly enlarging area, nipple discharge, or skin changes requires urgent assessment to exclude male breast cancer.
New Adult-Onset Gynecomastia
When there is no clear trigger such as puberty, obesity, or medication, hormonal and systemic causes should be investigated.
Signs of Low Testosterone
Reduced libido, worsening fatigue, loss of body hair, or testicular atrophy requires a complete hormonal assessment.
Headaches or Visual Changes
When these symptoms occur alongside gynecomastia, a pituitary cause such as hyperprolactinemia must be considered.
Persistent Pubertal Gynecomastia
Specialist review is appropriate when it persists beyond 24 months or causes significant psychological distress.
Physiological pubertal gynecomastia without concerning features
An adolescent boy can initially be managed with observation and reassurance because the condition commonly resolves spontaneously. Assessment is still appropriate if symptoms change, the diagnosis is uncertain, it persists beyond two years, or it affects emotional wellbeing.
Complications of Untreated Gynecomastia
The consequences depend on the underlying cause. The main clinical risk is treating the visible breast tissue while the hormonal, medication-related, or medical driver remains unidentified.
Missed Underlying Diagnosis
Gynecomastia may be the first sign of a testicular tumour, pituitary adenoma, or hypogonadism. Delayed assessment can leave cancer, visual risk, bone loss, muscle decline, or cardiovascular risk unaddressed.
Fibrosis Can Limit Medical Treatment
Early glandular tissue may respond to treatment. After roughly 12 months it can become progressively fibrotic, making medication less effective and increasing the likelihood that surgery will be needed.
Psychological Impact
Chest-related embarrassment can reduce confidence and lead to avoidance, anxiety, or depression, particularly during adolescence. These effects are genuine and deserve appropriate clinical support.
Medication-Induced Gynecomastia
If the causative medicine continues unchanged, glandular growth may persist and eventually become fibrotic. Early review can allow a safe alternative before tissue changes become difficult to reverse.
How Gynecomastia Is Diagnosed in Dubai
Diagnosis combines clinical examination with targeted hormonal and biochemical testing. Dr. Ali identifies both the type of breast tissue and its underlying cause before any treatment is considered.
Physical examination
Clinical Assessment: True vs Pseudo
Palpation distinguishes firm, nipple-centred glandular tissue from soft, diffuse pseudogynecomastia. Unilateral growth, skin changes, or nipple discharge prompts breast imaging to exclude malignancy.
Hormonal investigation
Core Hormonal Panel
Total testosterone and LH assess hypogonadism; estradiol, prolactin, beta-hCG, SHBG, and thyroid testing investigate aromatase excess, pituitary disease, testicular tumours, and reduced free androgen activity.
Systemic screening
Liver Function and Metabolic Panel
Liver and kidney function, a full blood count, and a complete metabolic panel identify systemic causes that may alter hormone metabolism and require treatment before direct gynecomastia intervention.
Targeted investigation
Targeted Imaging
Results guide the next test: testicular ultrasound for suspicious hormonal findings, breast ultrasound or mammography for concerning breast changes, and pituitary MRI when prolactin is significantly elevated.
Gynecomastia Treatment in Dubai: From Medication Review to Surgery
Gynecomastia treatment in Dubai is matched to the underlying cause. Early, active glandular tissue may respond to medical treatment, while established fibrotic gynecomastia usually requires surgical referral.
Treating the Underlying Cause First
Care may involve cabergoline for hyperprolactinemia, hormonal therapy for confirmed hypogonadism, changing a causative medication, or structured weight management for obesity-related cases.
Tamoxifen
Tamoxifen blocks estrogen activity at breast tissue receptors and is most effective for recent, tender, non-fibrotic gynecomastia. Response is reviewed during a supervised 3-to-6-month course.
Raloxifene
Raloxifene is another selective estrogen receptor modulator that may benefit active gynecomastia and can be better tolerated by some patients. Suitability is assessed individually by an endocrinologist.
Surgical Referral for Fibrotic Gynecomastia
Tissue present for 12 to 18 months may no longer respond to medication. Dr. Ali completes the hormonal workup and addresses the cause before referral, helping reduce recurrence after surgery.
Why Choose Dr. Ali Aldibbiat for Gynecomastia Treatment in Dubai?
With 20+ years of specialist experience, dual FRCP fellowships, and a PhD in hormonal and metabolic science, Dr. Ali identifies why gynecomastia developed before recommending medication or surgery.
Fact-checked by Dr. Ali Aldibbiat | MD | PhD | FRCP (London) | FRCP (Edinburgh) | FACE | Associate Professor.
Cause Identification Before Any Decision
A hormonal panel, medication review, and targeted imaging determine whether care should address prolactin, testosterone, medication exposure, weight, or established breast tissue.
Acting Before Fibrosis
Active gynecomastia may respond to medical treatment during its first 12 months. Early assessment preserves the best chance of improvement without surgery.
Medication-Induced Gynecomastia
Spironolactone, finasteride, anabolic steroids, and some antipsychotics can contribute. Where clinically safe, reviewing the causative medication may prevent progression.
What Our Patients Say
Genuine Google reviews reflecting Dr. Ali's experience, careful assessment, and patient-centred endocrine care.
“I would like to thank Dr. Ali Aldibbiat. He is an exceptional doctor, highly experienced in his specialty, and fully dedicated to his patients' healing.”
“The hospital has very great services and experienced doctors. Thanks to Dr. Ali Aldibbiat, he knew my issues from the first time. Although I have been to many places, no one could find what I was going through.”
“I visit Dr. Ali AlDibbiat, the endocrinologist here, who is excellent and very patient. His treatment has significantly improved my diabetes control.”
Related Male Hormonal Health Conditions
Explore connected male hormonal and pituitary conditions that may contribute to gynecomastia or influence its treatment.
Male Hormonal Health Hub
Explore testosterone deficiency, erectile dysfunction, gynecomastia, and male fertility care in Dubai.
Androgen assessmentLow Testosterone
Testosterone deficiency is an important hormonal cause of gynecomastia, requiring full assessment and appropriate management.
Pituitary connectionHyperprolactinemia
Elevated prolactin can suppress testosterone and cause gynecomastia; treating the pituitary cause can address both.
Gynecomastia Treatment Near Me: Dubai and UAE Service Areas
Dr. Ali Aldibbiat provides specialist, cause-led gynecomastia assessment from his Jumeirah clinic, welcoming patients from across Dubai and the wider UAE.
Specialist hormonal assessment in Jumeirah
The clinic at 109 Century Plaza, Jumeirah Beach Road, serves patients seeking gynecomastia treatment from Jumeirah, Downtown Dubai, DIFC, Dubai Marina, Deira, Bur Dubai, JBR, Al Quoz, and Mirdif. Patients also attend from Abu Dhabi, Sharjah, and across the UAE.
Searching for a gynecomastia treatment, male breast, or endocrinology specialist near you in Dubai? Contact Dr. Ali's clinic to arrange an assessment.
Frequently Asked Questions: Gynecomastia Treatment in Dubai
Gynecomastia is the benign proliferation of glandular breast tissue in men, caused by an imbalance between estrogen and androgen activity in breast tissue. It does not itself require urgent gynecomastia treatment dubai in most cases, but it can be a sign of an underlying hormonal condition such as hypogonadism, hyperprolactinemia, or rarely a testicular tumor that does require treatment. Dr. Ali Aldibbiat provides specialist gynecomastia treatment in Dubai with a complete hormonal assessment to identify the underlying cause.
Gynecomastia is caused by a relative excess of estrogen compared to androgen at the breast tissue level. Common causes include pubertal hormonal changes (most common in adolescents); low testosterone from any cause; obesity and increased aromatase activity; medications (spironolactone, finasteride, anabolic steroids, and certain antipsychotics); hyperprolactinemia from a pituitary adenoma; liver disease; and hyperthyroidism. Identifying the specific cause is the foundation of gynecomastia treatment dubai.
Pubertal gynecomastia resolves spontaneously in most adolescents within 6 to 24 months without treatment. Adult gynecomastia from an identifiable cause (medication, hypogonadism, hyperprolactinemia) usually resolves when the cause is treated, provided the glandular tissue has not yet become fibrotic. Established gynecomastia present for more than 12 to 18 months is unlikely to resolve without gynecomastia treatment dubai: medical or surgical intervention.
Non-surgical gynecomastia treatment in Dubai includes treating the underlying hormonal cause (testosterone replacement for hypogonadism, cabergoline for hyperprolactinemia), stopping or switching a causative medication, medical treatment with tamoxifen or raloxifene to block estrogen action in breast tissue, and weight management where obesity is contributing. Medical gynecomastia treatment dubai is most effective when gynecomastia is active and has been present for less than 12 months.
No. Gynecomastia is a benign, bilateral or unilateral glandular proliferation that is centrally located beneath the nipple. Male breast cancer is typically unilateral, eccentrically placed, firm, fixed, associated with nipple discharge or skin changes, and does not correspond to the pubertal, drug-related, or hormonal pattern of gynecomastia. Any rapidly growing, unilateral, firm, or suspicious breast mass should be assessed urgently. Dr. Ali Aldibbiat always excludes malignancy as part of the initial gynecomastia treatment dubai assessment.
A consultant endocrinologist is the most appropriate specialist for gynecomastia in Dubai, as the condition is fundamentally hormonal and most cases have a treatable endocrine cause. Dr. Ali Aldibbiat provides specialist gynecomastia treatment dubai at 109 Century Plaza, Jumeirah Beach Road, Jumeirah 1. Searching for gynecomastia treatment near me or a gynecomastia treatment Dubai specialist? Book at /contact/book-appointment/ or call +971 58 588 2295.